Frontier Capital Management Co. LLC acquired a new position in Humana Inc. (NYSE:HUM – Get Rating) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 137,088 shares of the insurance provider's stock, valued at approximately $64,167,000. Humana accounts for 0.7% of Frontier Capital Management Co. LLC's holdings, making the stock its 27th biggest position. Frontier Capital Management Co. LLC owned approximately 0.11% of Humana at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of the business. Riverview Trust Co purchased a new position in shares of Humana in the 1st quarter valued at approximately $32,000. Transcend Capital Advisors LLC lifted its stake in shares of Humana by 18.3% in the 1st quarter. Transcend Capital Advisors LLC now owns 587 shares of the insurance provider's stock valued at $255,000 after purchasing an additional 91 shares during the period. Townsend & Associates Inc purchased a new position in shares of Humana in the 2nd quarter valued at approximately $206,000. Krane Funds Advisors LLC lifted its stake in shares of Humana by 4.2% in the 1st quarter. Krane Funds Advisors LLC now owns 889 shares of the insurance provider's stock valued at $387,000 after purchasing an additional 36 shares during the period. Finally, Private Advisor Group LLC lifted its stake in shares of Humana by 32.3% in the 2nd quarter. Private Advisor Group LLC now owns 15,520 shares of the insurance provider's stock valued at $7,265,000 after purchasing an additional 3,788 shares during the period. Hedge funds and other institutional investors own 93.50% of the company's stock.
Get
Humana alerts:
Analyst Upgrades and Downgrades
HUM has been the subject of a number of research analyst reports. SVB Leerink raised their target price on Humana from $535.00 to $540.00 and gave the company an "outperform" rating in a research note on Thursday, July 28th. Oppenheimer raised their price objective on Humana from $520.00 to $550.00 and gave the company an "outperform" rating in a research report on Friday, September 16th. Morgan Stanley raised Humana from an "equal weight" rating to an "overweight" rating and raised their price objective for the company from $494.00 to $549.00 in a research report on Tuesday, September 20th. Deutsche Bank Aktiengesellschaft raised their price objective on Humana from $450.00 to $514.00 in a research report on Thursday, July 28th. Finally, Royal Bank of Canada raised their price objective on Humana from $541.00 to $544.00 and gave the company an "outperform" rating in a research report on Tuesday, September 20th. Four research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $519.28.
Humana Stock Performance
Shares of HUM traded down $4.47 during trading hours on Thursday, hitting $489.34. The stock had a trading volume of 3,235 shares, compared to its average volume of 992,934. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.53 and a quick ratio of 1.53. Humana Inc. has a 12 month low of $351.20 and a 12 month high of $514.98. The firm has a market capitalization of $61.93 billion, a PE ratio of 20.16, a PEG ratio of 1.42 and a beta of 0.77. The stock has a fifty day moving average price of $487.66 and a 200 day moving average price of $462.64.
Humana (NYSE:HUM – Get Rating) last issued its quarterly earnings data on Wednesday, July 27th. The insurance provider reported $8.67 EPS for the quarter, topping the consensus estimate of $7.67 by $1.00. Humana had a return on equity of 18.42% and a net margin of 3.52%. The company had revenue of $23.66 billion during the quarter, compared to analyst estimates of $23.44 billion. During the same quarter in the previous year, the company posted $6.89 earnings per share. Humana's revenue was up 14.6% compared to the same quarter last year. Analysts anticipate that Humana Inc. will post 25.01 EPS for the current year.
Humana Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, September 30th will be given a dividend of $0.7875 per share. The ex-dividend date is Thursday, September 29th. This represents a $3.15 annualized dividend and a yield of 0.64%. Humana's dividend payout ratio (DPR) is presently 12.86%.
Insider Activity at Humana
In related news, insider Joseph C. Ventura sold 1,226 shares of Humana stock in a transaction on Tuesday, September 20th. The stock was sold at an average price of $506.78, for a total transaction of $621,312.28. Following the transaction, the insider now directly owns 3,930 shares in the company, valued at $1,991,645.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.39% of the stock is owned by company insiders.
About Humana
(Get Rating)
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Stories
- Get a free copy of the StockNews.com research report on Humana (HUM)
- This Little Known Small Cap Is Up 139%: Is The Stock A Buy?
- A Trio of Q3 Winners With Room to Run
- Can HCA Healthcare Weather the Normalization?
- Can United Natural Foods Fight Both Inflation and the Fed?
- Mullen Automotive Is Ready To Get In Gear
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
